Earnings Per Share, Diluted of NovaBay Pharmaceuticals, Inc. from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Summary
NovaBay Pharmaceuticals, Inc. quarterly and annual Earnings Per Share, Diluted in USD/shares history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • NovaBay Pharmaceuticals, Inc. Earnings Per Share, Diluted for the quarter ending 30 Sep 2025 was -0.22, a 89% increase year-over-year.
  • NovaBay Pharmaceuticals, Inc. annual Earnings Per Share, Diluted for 2020 was -0.31, a 35% increase from 2019.
  • NovaBay Pharmaceuticals, Inc. annual Earnings Per Share, Diluted for 2019 was -0.48, a 4.3% decline from 2018.
  • NovaBay Pharmaceuticals, Inc. annual Earnings Per Share, Diluted for 2018 was -0.46, a 4.2% increase from 2017.
Source SEC data
View on sec.gov
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Quarterly (USD/shares)
Earnings Per Share, Diluted, YoY Quarterly Change (%)
Earnings Per Share, Diluted, Annual (USD/shares)
Earnings Per Share, Diluted, YoY Annual Change (%)

NovaBay Pharmaceuticals, Inc. Quarterly Earnings Per Share, Diluted (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 -0.22 +1.7 +89% 01 Jul 2025 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 -0.33 +1.04 +76% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 1.42 +31.37 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q3 2024 -1.92 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2025 2025 Q3
Q2 2024 -1.37 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 -29.95 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q3 2020 -0.08 -0.06 -300% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q4 2019 0 -0.07 +0.02 +22% 01 Oct 2019 31 Dec 2019 10-K 25 Mar 2021 2020 FY
Q3 2019 0 -0.02 +0.09 +82% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020 2020 Q3
Q2 2019 0 -0.14 -0.02 -17% 01 Apr 2019 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 0 -0.25 -0.11 -79% 01 Jan 2019 31 Mar 2019 10-Q 15 May 2019 2019 Q1
Q4 2018 0 -0.09 -0.14 -280% 01 Oct 2018 31 Dec 2018 10-K 25 Mar 2021 2020 FY
Q3 2018 0 -0.11 +0.05 +31% 01 Jul 2018 30 Sep 2018 10-Q 07 Nov 2019 2019 Q3
Q2 2018 0 -0.12 -0.01 -9.1% 01 Apr 2018 30 Jun 2018 10-Q 07 Aug 2019 2019 Q2
Q1 2018 0 -0.14 +0.12 +46% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019 2019 Q1
Q4 2017 0 0.05 01 Oct 2017 31 Dec 2017 10-K 26 Mar 2020 2019 FY
Q3 2017 -0.16 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018 2018 Q3
Q2 2017 -0.11 01 Apr 2017 30 Jun 2017 10-Q 07 Aug 2018 2018 Q2
Q1 2017 -0.26 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018 2018 Q1
Q3 2013 -0.1 -0.1 01 Jul 2013 30 Sep 2013 10-Q 14 Nov 2013 2013 Q3
Q3 2012 0 0 01 Jul 2012 30 Sep 2012 10-Q 14 Nov 2013 2013 Q3
Q2 2012 -0.08 -0.1 -500% 01 Apr 2012 30 Jun 2012 10-Q 09 Aug 2012 2012 Q2
Q3 2011 0 01 Jul 2011 30 Sep 2011 10-Q 01 Nov 2012 2012 Q3
Q2 2011 0.02 01 Apr 2011 30 Jun 2011 10-Q 09 Aug 2012 2012 Q2

NovaBay Pharmaceuticals, Inc. Annual Earnings Per Share, Diluted (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2020 -0.31 +0.17 +35% 01 Jan 2020 31 Dec 2020 10-K 25 Mar 2021 2020 FY
2019 -0.48 -0.02 -4.3% 01 Jan 2019 31 Dec 2019 10-K 25 Mar 2021 2020 FY
2018 -0.46 +0.02 +4.2% 01 Jan 2018 31 Dec 2018 10-K 25 Mar 2021 2020 FY
2017 -0.48 +0.92 +66% 01 Jan 2017 31 Dec 2017 10-K 26 Mar 2020 2019 FY
2016 -1.4 +5.42 +79% 01 Jan 2016 31 Dec 2016 10-K 29 Mar 2019 2018 FY
2015 -6.82 +0.83 +11% 01 Jan 2015 31 Dec 2015 10-K 21 Mar 2018 2017 FY
2014 -7.65 +2.86 +27% 01 Jan 2014 31 Dec 2014 10-K 23 Mar 2017 2016 FY
2013 -10.51 -10.27 -4279% 01 Jan 2013 31 Dec 2013 10-K 04 Mar 2016 2015 FY
2012 -0.24 -0.04 -20% 01 Jan 2012 31 Dec 2012 10-K 26 Mar 2015 2014 FY
2011 -0.2 -0.02 -11% 01 Jan 2011 31 Dec 2011 10-K 06 Mar 2014 2013 FY
2010 -0.18 01 Jan 2010 31 Dec 2010 10-K 14 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.